ResearcherSir Run Run Shaw HospitalActive in the last 2 years
Xiaolong Liu
Matched on OpenAlex author ID A5123364923. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. Last author DOI 10.2147/dddt.s568812↗
- Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Path… Co-author DOI 10.1155/2022/3341038↗
- Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. First author DOI 10.1016/j.intimp.2020.106982↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Defei Hong · 2 shared papers, 2021–2022 · strength 0.37
- Paper Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by … DOI 10.1155/2022/3341038↗
- Paper Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic … DOI 10.1016/j.intimp.2020.106982↗
- Guixing Jiang · 1 shared paper, 2026 · strength 0.30
- Jiandong Zhang · 1 shared paper, 2026 · strength 0.30
- HuaGen Li · 1 shared paper, 2022 · strength 0.20
- Xueyong Zheng · 1 shared paper, 2021 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.